Showing results (251-260 of 345) with videos related to

Sort By:
Pageof 35
Journal of the American College of Cardiology|September 1, 2018
Identifying Pathophysiological Mechanisms in Heart Failure With Reduced Versus Preserved Ejection FractionJasper Tromp, B Daan Westenbrink, Wouter Ouwerkerk, et al.
European Journal of Heart Failure|October 30, 2015
Plasma kidney injury molecule-1 in heart failure: renal mechanisms and clinical outcomeJohanna E Emmens, Jozine M Ter Maaten, Yuya Matsue, et al.
Journal of the American College of Cardiology|February 28, 2024
Angiotensin Receptor-Neprilysin Inhibition in Patients With STEMI vs NSTEMIDouglas L Mann, Johny Nicolas, Brian Claggett, et al.
European Heart Journal|June 27, 2022
A circular RNA derived from the insulin receptor locus protects against doxorubicin-induced cardiotoxicityDongchao Lu, Shambhabi Chatterjee, Ke Xiao, et al.
International Journal of Cardiology|September 24, 2016
Use of biomarkers to establish potential role and function of circulating microRNAs in acute heart failureEline L Vegter, Daniela Schmitter, Yanick Hagemeijer, et al.
Heart (British Cardiac Society)|September 24, 2016
Blood urea nitrogen-to-creatinine ratio in the general population and in patients with acute heart failureYuya Matsue, Peter van der Meer, Kevin Damman, et al.
European Journal of Heart Failure|August 8, 2024
Living with peripartum cardiomyopathy: A statement from the Heart Failure Association and the Association of Cardiovascular Nursing and Allied Professions of the European Society of CardiologyKaren Sliwa, Amina Rakisheva, Charle Viljoen, et al.
European Journal of Heart Failure|June 28, 2019
Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathyJohann Bauersachs, Tobias König, Peter van der Meer, et al.
European Journal of Heart Failure|March 11, 2025
Update on preclinical models of cancer therapy-related cardiac dysfunction: Challenges and perspectives. A scientific statement of the Heart Failure Association (HFA) of the ESC, the ESC Council of Cardio-Oncology, and the ESC Working Group on Cellular Biology of the HeartAlessandra Ghigo, Pietro Ameri, Aarti Asnani, et al.
European Journal of Heart Failure|November 22, 2024
State of the art and perspectives of gene therapy in heart failure. A scientific statement of the Heart Failure Association of the ESC, the ESC Council on Cardiovascular Genomics and the ESC Working Group on Myocardial & Pericardial DiseasesSophie Van Linthout, Konstantinos Stellos, Mauro Giacca, et al.
Pageof 35